Stay updated on PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page; no changes to study details, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-03-12T20:39:40.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed, replacing Revision: v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-12T02:26:00.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.4.0 to v3.4.1; there are no changes to study content or user-facing functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:39:05.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a Show glossary toggle and updated footer/site metadata to Revision: v3.4.0, while removing the labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T21:24:58.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 replaces v3.3.3 on the page. No visible changes to the study details or layout.
    Difference
    0.1%
    Check dated 2026-01-14T03:57:20.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Added a Locations section with Surrey, removed the Surrey Locations entry and the HHS Vulnerability Disclosure, and updated the page revision from v3.3.2 to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T20:56:45.000Z thumbnail image

Stay in the know with updates to PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PERSEUS1: Pembrolizumab in Advanced Prostate Cancer Clinical Trial page.